Taken together, these data suggest that SRC catalyze regenerative outcomes in the kidney in part by activating multiple transcriptomic networks associated with the promotion of regeneration while simultaneously suppressing alternate transcriptional pathways that may promote the continued development of renal disease and pathophysiology, see Additional file 1: Figure S17. The gene discussed is SRC; the disease is kidney disorder.